Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study
Key facts
- Who runs it
- ResMed
- Where
- Australia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 10 Apr 2025
- Planned end
- Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Investigational algorithm
- Control algorithm
- Record updated
- 2 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Participants willing to give written informed consent
- Participants who can read and comprehend English
- Participants who ≥ 18 years of age
- Participants who have been using a ResMed AirSense 10 or 11 device
- Participants currently using AutoSet (APAP) mode
- Participants being established on PAP therapy for the treatment of OSA for approximately >3 months
- Participants who can participate in the study for up to 8 weeks
Who cannot take part
- Participants with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury
- Participants using Bilevel flow generators
- Participants using CPAP, AutoSet for Her
- Participants who are or may be pregnant
- Participants believed to be unsuitable for inclusion by the researcher
- Participants who are currently enrolled in other medical clinical studies
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to assess the effectiveness of an investigational algorithm in the treatment of obstructive sleep apnea.
The 2 groups in the trial
- Investigational algorithmTreatment being tested
The participants will trial the investigational algorithm and the control algorithm in a randomized order. Each will be used for up to 4 weeks in the home environment in place of their own device/therapy. The study device will be set up to align with the majority of the participants current therapy settings.
- Control algorithmExisting treatment, for comparison
The participants will trial the investigational algorithm and the control algorithm in a randomized order. Each will be used for up to 4 weeks in the home environment in place of their own device/therapy. The study device will be set up to align with the majority of the participants current therapy settings.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 2 December 2025